Global Peptide Therapeutics Market & Clinical Trials Insight Report 2022: Market Set to Surpass US$ 75 Billion by 2028 - ResearchAndMarkets.com
Retrieved on:
Friday, May 6, 2022
Health, Pharmaceutical, Dermatology, Peptide therapeutics, US, Gastroenterology, Company, Bone, Peptide, Endocrinology, Contract, Prevalence, Indication, Insulin, Attention, Degenerative disease, Cancer, Diabetes, Therapy, Industry, Conditional sentence, Vaccine, Glucagon-like peptide-2, Genentech, Organic acid, Research, Lists of diseases, Growth, Sexual dysfunction, Fine chemical, Neuropeptide, Glycopeptide, Natriuresis, Dipeptide, Depsipeptide, Oligopeptide, Lipopeptide
The "Global Peptide Therapeutics Market & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Global Peptide Therapeutics Market & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.
- Currently, more than 800 clinical trials are ongoing in global peptide therapeutics market which suggests a promising future of peptide therapeutics in the forthcoming years.
- Keeping the clinical pipeline into consideration, it is expected that the global peptide therapeutics market will surpass US$ 75 Billion by 2028.
- Global Peptide Therapeutics Market & Clinical Trials Insight 2028 Report highlights:
Global Peptide Therapeutics Clinical Trials Insight by Company, Indication & Phase
Peptide Therapeutics in Clinical trials: > 800 Drugs
Peptide Therapeutics Commercially Available In Market: > 200 Drugs
Global Peptide Therapeutics Clinical Trials Insight By Peptide Type: Glucagon-like Peptides, Cyclic Peptides, Glycopeptides, Oligopeptides, Lipopeptides, Dipeptides, Opioid, Depsipeptides, Neuropeptides, Natriuretic, Bicyclic Peptides